Short boys treated with growth hormone show normal progression of testicular size and achieve normal serum testosterone concentrations.

What Was Tested

This clinical trial looks at Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

To determine whether there is evidence for impaired testicular function at final height in short boys treated with growth hormone (GH) during their childhood and adolescence.

Who Took Part

The study group was 77 boys.

The age groups tagged for this paper are young children, children and teenagers, men only.

One hundred and eleven boys fulfilled the criteria.

Testicular volumes were determined by orchidometer in each boy when GH treatment was started and at final height.

How the Study Was Run

The analysis was restricted to males who had isolated GH deficiency or idiopathic short stature, and who were included in the Swedish National Registry and the Swedish GH trials.

Samples for testosterone measurements were collected from 77 boys at final height, and were measured by RIA.

What Was Measured

Topics PubMed links to this paper include Body Height, Circadian Rhythm, Growth Hormone, Metabolism, Inborn Errors, Osmolar Concentration, Testis and Testosterone.

What This Means in Plain Language

This is a clinical trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 77 boys.

Its findings take up roughly 2 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2002 (European journal of endocrinology), a journal based in England.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.